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Abstract: Heterogeneity is a fact that plagues the characterization and application of many 
self-assembled biological constructs. The importance of obtaining particle homogeneity in 
biological assemblies is a critical goal, as bulk analysis tools often require identical species 
for reliable interpretation of the results—indeed, important tools of analysis such as x-ray 
diffraction typically require over 90% purity for effectiveness. This issue bears particular 
importance in the case of lipoproteins. Lipid-binding proteins known as apolipoproteins 
can self assemble with liposomes to form reconstituted high density lipoproteins (rHDLs) 
or nanolipoprotein particles (NLPs) when used for biotechnology applications such as the 
solubilization of membrane proteins. Typically, the apolipoprotein and phospholipids 
reactants are self assembled and even with careful assembly protocols the product often 
contains heterogeneous particles. In fact, size polydispersity in rHDLs and NLPs published 
in the literature are frequently observed, which may confound the accurate use of analytical 
methods. In this article, we demonstrate a procedure for producing a pure, monodisperse 
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NLP subpopulation from a polydisperse self-assembly using size exclusion chromatography 
(SEC) coupled with high resolution particle imaging by atomic force microscopy (AFM). 
In addition, NLPs have been shown to self assemble both in the presence and absence of 
detergents such as cholate, yet the effects of cholate on NLP polydispersity and separation 
has not been systematically examined. Therefore, we examined the separation properties of 
NLPs assembled in both the absence and presence of cholate using SEC and native gel 
electrophoresis.  From this analysis, NLPs prepared with and without cholate showed 
particles with well defined diameters spanning a similar size range. However, cholate was 
shown to have a dramatic affect on NLP separation by SEC and native gel electrophoresis.  
Furthermore, under conditions where different sized NLPs were not sufficiently separated 
or purified by SEC, AFM was used to deconvolute the elution pattern of different sized 
NLPs. From this analysis we were able to purify an NLP subpopulation to 90% size 
homogeneity by taking extremely fine elutions from the SEC.  With this purity, we 
generate high quality NLP crystals that were over 100 μm in size with little precipitate, 
which could not be obtained utilizing the traditional size exclusion techniques. This 
purification procedure and the methods for validation are broadly applicable to other 
lipoprotein particles. 
 
Keywords: apolipoproteins; nanolipoprotein particles; bilayer mimetic; nanobiotechnology; 
atomic force microscopy; size-exclusion chromatography; lipoprotein crystallization 
 
 
1. Introduction 
 
Recently, it has been demonstrated that purified apolipoproteins and liposomes can self-assemble in 
vitro to form discoidal bilayer patches (referred to as nanolipoprotein particles, NLPs) where the 
lipoproteins are localized to the perimeter [1-12]. These self-assembling membrane mimetics are 
currently used in biotechnology applications for the solubilization of membrane proteins [13-17].   
Important applications of these technology include their use in understanding the function of 
membrane protein complexes [18] and expressing functional membrane proteins without the use of 
cells [19]. Despite the potential use of NLPs as a robust model membrane system, the self-assembly 
process results in particle size variability [2,20,21], where NLP size can span tens of nanometers.  
Several studies have suggested that the origin of this polydispersity results from different numbers of 
lipid and apolipoprotein per particle [3,11,22].  
Two predominant techniques have been developed for efficient NLP assembly and the major 
difference between these two techniques is the addition of a detergent, typically cholate, during 
assembly. In the first method, referred to as cholate-associated assembly, cholate is added to the lipid 
suspension at a concentration that is above the critical micelle concentration (CMC), resulting in a 
solution of micelles that consist of cholate and lipid [3,15,16,23,24].  NLPs are then assembled 
through the addition of an apolipoprotein followed by cholate dialysis. Presumably, the lipoproteins 
initially associate with the lipid/cholate micelles and upon removal of cholate through dialysis 
discoidal NLPs form [3,11,12,15,16]. In the second method, referred to as cholate-free assembly, a Int. J. Mol. Sci. 2009, 10                 
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multilamellar vesicle suspension is tip sonicated to form a lipid suspension of small unilamellar 
vesicles (SUVs) [11,12,25,26]. This is followed by the addition of apolipoproteins and a 24 hour 
temperature transition cycle where the reaction temperature is cycled above and below the phase 
transition temperature of the lipids used for assembly. Presumably the temperature transition cycle 
promotes defects in the SUVs which allow the lipoproteins to diffuse into the bilayer and repackage 
lipid into NLPs.   
We have recently characterized NLPs assembled from apoE422k (the N-terminal 22 kDa fragment 
of apolipoprotein E4) and DMPC using the cholate-free assembly method by size exclusion 
chromatography (SEC), native gel electrophoresis, atomic force microscopy (AFM), ion mobility 
spectroscopy (IMS) and transmission electron microscopy (TEM) [11]. We observed that NLPs 
assembled in the absence of cholate displayed a single peak by SEC and a single band by native gel, 
which suggested that the NLPs were monodisperse or homogeneous in size [11]. However, when the 
particle sizes were examined by AFM, IMS and TEM four discrete NLP sizes were observed 
indicating that the NLP size distribution was actually highly polydisperse [11]. Although the focus of 
this work was characterization of NLPs sizes and not purification, the results suggested that utilizing 
the dominant elution peak during separation by SEC and native gel electrophoresis was not sufficient 
to separate NLP sub populations under these conditions [11]. This was a surprising result because both 
of these methods should have the resolving power to separate particles over the size range we observed 
for E422k-NLPs and these methods have been used to produce monodisperse results and to accurately 
assess the heterogeneity of NLPs formed with other scaffolds such as human apolipoprotein A1 
[15,16,25-28]. Our conclusions from these findings are that some techniques such as SEC or native gel 
electrophoresis do not separate a subset of heterogeneous lipoprotein samples according to the 
specification of the separation device; therefore it is important to couple sample separation with high 
resolution characterization methods. Moreover, other methods for lipoprotein separation, such as field-
flow fractionation (FFF) may provide improved fractionation of delicate nanoparticles [29]. 
We have comparatively examined the separation of different sized NLPs assembled from apoE422k 
and DMPC in both the absence and presence of cholate by SEC and native gel electrophoresis and 
report a method to produce homogeneous NLP sub-populations. To assess the importance of NLP 
monodispersity, heterogeneous and homogeneous NLP sub-populations were subjected to de novo 
crystallization to determine the effect of NLP homogeneity on crystal quality. 
 
2. Results and Discussion 
 
2.1. Effect of cholate on NLP separation by SEC and native gel electrophoresis 
 
When NLPs, assembled using the cholate-free method, were purified by SEC only a singe NLP rich 
peak was observed (Figure 1A) [6,11,12]. NLP fractions were pooled from the NLP-rich peak and 
subjected to native gel electrophoresis (Figure 1B). As previously observed, there was a single NLP 
peak by SEC (Figure 1A) and a single band by native gel electrophoresis (600 kDa) (Figure 1B – 
lane 2), indicating assembly resulted in homogeneous NLPs that were presumably monodisperse in 
size. However, multiple sized species with four discrete diameters centered at ~14.5, 19, 23.5 and 
28 nm were consistently observed by AFM (Figure 1C). In addition, in previous work we showed that Int. J. Mol. Sci. 2009, 10                 
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these discrete sizes were not a result of an artifact of AFM imaging, such as tip-sample convolution, 
and similar discrete sizes were observed with other high resolution techniques such as electron 
microscopy and ion mobility spectroscopy [11]. It is also worth noting that the majority of NLPs were 
smaller than 25 nm and the SEC column used in this study (Superdex 200 HR 10/300 column) was 
expected to efficiently separate these different sized NLP constructs.   
 
Figure 1. Effect of cholate on NLP size as characterized by SEC, Native gel 
electrophoresis, and AFM.  A. SEC trace, B. Native gel electrophoresis and C. AFM image 
analysis of NLPs assembled using the cholate-free method. Inset AFM image of the four 
predominant NLP sizes.  Scale bar 25 nm.  D. SEC trace, E. Native gel electrophoresis, and 
F. AFM image analysis of NLPs assembled using the cholate-associated method.  G. SEC 
trace, H. Native gel electrophoresis, and I. AFM image analysis of NLPs assembled using 
the cholate-associated method in the presence of 0 mM and 5 mM cholate.  In G. and I. 
black line – 0 mM cholate, blue line – 5mM cholate.  
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To examine the effects of cholate, NLPs assembled using the cholate-associated method were also 
subjected to SEC purification, native gel electrophoresis and AFM image analysis.  In contrast to the 
results obtained using the cholate-free method, three NLP-rich peaks were observed by SEC   
(Figure 1D). In addition, when these three peaks (P1, P2, and P3) were subjected to native gel 
electrophoresis a single band, two bands and three bands were observed in P1, P2, and P3, respectively 
(Figure 1 E).  Unexpectedly, the single band in P1 and the highest MW bands in P2 and P3 migrated to 
the same MW, (600 kDa), and the lowest molecular weight band in P2 and the middle band in P3 also 
all migrated to the same MW (500 kDa). In addition, there was a low molecular weight band in 
P3 (324 kDa) that was not observed in the other two peaks. These banding patterns strongly suggest 
that these particles represent discrete NLP sizes. When each peak was analyzed by AFM a very similar 
sizing pattern was observed (Figure 1F). P3 consisted of a single size NLP centered at 23.5 nm in 
diameter. However, two (19.0 and 23.5 nm) and three (14.5, 19.0, and 23.5 nm) different sized NLPs 
were observed in P2 and P3, respectively (Figure 1F). The diameter distributions of P1, P2 and P3 
corresponded very closely with the banding patterns observed by native gel, where one, two and three 
different NLP sizes determined by AFM and native gel bands were observed in P1, P2 and P3, 
respectively (Figure 1E and 1F). Interestingly, these discrete sizes were centered at the same means 
observed for the NLPs assembled in the absence of cholate and there was no dramatic change in 
particle shape, which suggests that cholate does not appreciably affect the overall structure of   
the NLPs. 
To assess whether the addition of cholate after cholate-free NLP assembly can promote separation 
by SEC and native gel, 5 mM cholate (below the CMC of cholate) was added to NLPs that were 
assembled in the absence of cholate.  Figures 1G and 1H are the SEC and native gels, respectively, of 
the NLPs before and after cholate addition. As shown in Figure 1D, the single NLP peak became more 
broad displaying two overlapping peaks after the addition of 5 mM cholate. In addition, the single 
band in the native gel became four bands, which closely corresponded to the diameter distribution 
determined by AFM. To determine the effect of the post-addition of cholate on the NLP diameter 
distributions, the sample was imaged both before and after cholate addition (Figure 1I).  From this 
analysis no changes were observed in either the mean or relative fraction of each discrete size 
(Figure 1I).  It is also worth noting that the emergence of a small lipid-rich peak in the SEC trace after 
cholate addition (Figure 1D) was observed, suggesting that a small fraction of the particles have 
started to disassemble. This was expected since detergents will also promote the formation of 
micelle/lipoprotein complexes [24]. However, we did not observe any micelle-like structures by AFM, 
indicating that the constructs in the lipid-rich region most likely do not have favorable interactions 
with the mica surface under the buffering conditions used. 
These combined results strongly suggest that even though the NLPs were dialyzed after cholate-
NLP assembly a portion of the cholate may remain associated with the NLP construct. This is not 
surprising since it is known that the amphiphilic nature of cholate will cause them to intercalate into 
the NLP bilayer, and removal through dialysis alone may not be sufficient to remove all of cholate that 
is anchored into the NLP bilayer.  The most intriguing aspect of these results is the effect cholate has 
on NLP separation by SEC and native gel. These results suggest that NLPs may be interacting with 
one another during electrophoresis and SEC purification such that different sized particles migrate to 
the same spot on native gel (~ 620 kDa) and elute with similar retention times during SEC purification. Int. J. Mol. Sci. 2009, 10                 
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Quite possibly, these interactions may be disrupted when negatively charged cholate becomes 
associated with the NLPs, allowing for improved separation during SEC and native gel 
electrophoresis.  It is worth noting that cholate appears to improve NLP separation with SEC, however 
both P2 and P3 still contained particles with a variety of diameters and thus are still polydisperse.  In 
addition, the fact that no change was observed after cholate addition indicates cholate does not 
appreciably affect the absolute size of these particles.   
 
2.2. De-convolution of the single NLP peak 
 
The observation that NLPs of different sizes all eluted in a single SEC peak when NLPs were 
assembled using the cholate-free method strongly suggest that the particles are interacting 
dynamically, but it is still unclear whether the elution pattern of these particles is consistent across the 
entire peak.  Therefore, the elution properties of the four different NLP sizes in the single NLP rich 
SEC peak were resolved by collecting 27 fractions across the entire peak and subjecting select 
fractions to AFM image analysis. In these experiments, two 20 mg NLP assemblies were pooled so 
there was sufficient material in each fraction for subsequent analysis.  
Figure 2A is a truncated SEC trace of the NLP-rich peak after large scale assembly using the 
Superdex 200 26/60 column at a flow rate of 2.5 mL/min. Similar to the small scale assemblies, only a 
single NLP-rich peak was observed; however the NLP retention times in these experiments were 
different than the small scale assemblies (Figure 1A) due to the use of a different column. The vertical 
lines represent the fractions that were collected throughout the NLP-rich peak.  NLP diameter 
distributions were determined by AFM and the relative fraction normalized to the SEC trace was 
calculated for each NLP size. Using this technique, the relationship between NLP size and elution time 
throughout the entire NLP-rich SEC peak was de-convoluted (Figure 2B).  Interestingly, the elution of 
the four NLP sizes was not consistent across the entire peak. In fact, the maximal peak in the elution of 
larger particles occurred at earlier times where the peak elution times for the 28.0, 23.5, 19.0 and 14.5 
nm NLPs were 49.9, 50.7, 51.5, 53.1 minutes, respectively (Figure 2B). Representative AFM images 
from three different fractions (highlighted in Figure 2A) are shown in Figure 2C. From these images it 
is clear that the size distributions vary throughout the NLP-rich peak.     
Interestingly, the elution width of the 14.5 nm peak was narrower than that of the other sized 
particles and the majority of these particles eluted slightly to the right of the center of the entire NLP-
rich peak (Figure 2B). Therefore, this region of the NLP-rich peak was highly enriched in the 14.5 nm 
size particle.  In fact ~70% of the NLPs that eluted from 52.9 – 53.3 minutes were the ~ 14.5 nm sized 
NLP (referred to as SEC #1 –Center Cut), as opposed to ~ 40% for the pooled NLP-rich peak (referred 
to as SEC #1 – All). These results suggest that a second SEC injection of this elution fraction should 
result in a narrowing and shift in the main NLP peak. When this was done the peak in fact did narrow 
and shift to the right, indicating a more homogeneous sample of smaller particles (Figure 3B). To 
determine if there was an increase in NLP homogeneity in the center cut of the re-injected sample 
various elution fractions around this region of the NLP peak were imaged by AFM.  Several fractions 
to the right of the center cut were found to be greater than 80% enriched in the 14.5 nm NLP but the 
fraction outlined by the black lines in Figure 3B (referred to as SEC #2 – Center Cut) was the fraction 
that contained the highest purity with 90% of the NLPs being ~ 14.5 nm in diameter (Figure 3C).  The Int. J. Mol. Sci. 2009, 10                 
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diameter distributions for the SEC #2 – Center Cut elution fraction and the SEC #1 – All elution 
fractions is given in Figure 3C.  In addition, the exact fraction of the four different sized NLPs in the 
SEC #1 – All, SEC #1 – Center Cut, and SEC #2 – Center Cut elution fractions are given in Figure 3D.   
 
Figure 2. AFM analysis of SEC fine elution fractionation vs. volume purification. A.  An 
expanded view of the NLP-rich peak under cholate-free assembly conditions.  Dashed lines 
indicate the fractions in which elutions were collected.  B.  Relative proportion of the four 
different sized NLPs in the SEC fine elution fractions.  Dashed line represents SEC trace. 
C.  Representative AFM images from the fractions highlighted in A., highlighted color of 
the fraction correspond to the images with the same colored border.  Scale bar 100 nm. 
 
 
These combined results indicate that the different sized particles are eluting as expected based on 
the principles of SEC but the presumed interactions severely tighten the difference in retention time; 
therefore, the different elution peaks of these particles appear as one single peak by SEC. Although the 
interactions severely hinder the ability of SEC to purify out a single NLP subpopulation it is possible 
to achieve homogeneity of the smallest 14.5 nm sized NLP through iterative SEC of the elution 
fraction that is to the right of the peak’s center.   
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Figure 3. Center-cut SEC re-injection selectively purifies the smallest 14.5 nm NLPs.  A.  
SEC trace of the first injection highlighting the NLP-rich peak (referred to as SEC #1).  
Dotted line indicates the center cut fraction that was subsequently re-injected (referred to 
as SEC #1 – CC).  B.  SEC trace of the second injection of the center cut material indicated 
in A., again highlighting the NLP-rich peak (referred to as SEC #2 - CC). Dashed SEC 
trace is the SEC #1 and black line represent the SEC fraction containing the most 
homogeneous NLP population (referred to as SEC #2 – CC).  C. Histogram of diameter 
distributions for the pooled NLP peak from of SEC #1 (gray line) and the SEC #2 – CC 
fraction (black line).  D.  Table of the fraction of discrete NLP sizes (14.5, 19, 23.5, 28 nm) 
for three different SEC fractions, SEC #1 – All, SEC #1 - CC, and SEC #2 – CC.  
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2.3. Effect of homogeneity on NLP crystallization 
 
One of the objectives of this study was to better understand the purification process of NLPs 
assembled using the cholate-free and cholate-associated methods in order to better produce 
homogeneous NLP sub-populations. The motivation for this approach is to utilize biophysical 
techniques that are sensitive to sample homogeneity. One such technique is the growth of high quality 
crystals for structural determination using X-ray crystallography. Obtaining discoidal lipoprotein 
crystals suitable for the determination of structure is a challenging task, although ellipsoidally-shaped Int. J. Mol. Sci. 2009, 10                 
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full length apoE4 structures have been determined [30]. The benefits of these structures would 
significantly improve rational design of membrane protein solubilizing in NLPs. ApoE422k is of 
particular interest for solubilization of membrane proteins as it produces larger particles compared to 
other apolipoproteins [12] which may be relevant when accommodating large membrane proteins and 
protein complexes. 
 
Figure 4. NLP crystal growth. A. Crystals grown from a polydisperse NLP sample (SEC 
#2 – CC).  B.  Crystals grown from a monodisperse NLP sample (SEC #1 – All). Scale bar 
200 um. 
 
 
To demonstrate the utility of a homogeneous and monodisperse NLP subpopulation, samples of 
varying homogeneity were subjected to de novo crystallization screening [31] and the quality of the 
resulting crystals were compared. For these studies, we chose to use NLPs assembled using the 
cholate-free method and side-by-side crystallization was carried out with NLPs pooled from the entire 
single NLP peak from the first SEC run (40% homogeneity) and NLPs from the two most 
homogeneous fractions from the second SEC run (90% homogeneity). Both samples showed a 
propensity to crystallize under similar conditions but the more homogeneous sample crystallized with 
higher propensity. However, there were notable differences in the crystallization habits of the two 
samples (Figure 4A and 4B). The less homogeneous sample tended to give smaller crystals that formed 
in the presence of an amorphous precipitate (Figure 4A) whereas the more homogeneous sample gave 
well formed crystals with less precipitate (Figure 4B). The best crystals, determined by crystal volume 
and clean morphology, were obtained from the more homogeneous sample. These results underline the 
benefit and importance of homogeneity for crystal growth. The largest crystals obtained to date from 
A. 
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the highly homogeneous sample were ~100 μm in maximum extent and were birefringent.   
Optimization efforts are currently underway to obtain larger crystals.   
 
3. Experimental Section 
 
3.1. Materials 
 
The phospholipid 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) was purchased from 
Avanti Polar Lipids, Inc. (Alabaster, AL).  
 
3.2. apoE422K protein production 
 
The expression clone to produce apoE422K, the N-terminal 22 kDa fragment of apolipoprotein E4 
(apoE4), as a 6His and thyrodoxin tagged construct was kindly provided by Dr. Karl Weisgraber. 
Production and purification of apoE422K has been described in detail elsewhere [12].   
 
3.3. Nanolipoprotein particle (NLP) formation 
 
NLP formation and purification both in the presence and absence of cholate have been described in 
detail elsewhere [12]. Briefly, dried DMPC was re-suspended in either 10 mM Tris pH 7.4, 0.15 M 
sodium chloride, 0.25 mM EDTA, 0.005% sodium azide (TBS) buffer followed by probe sonication to 
clarity (cholate-free assembly) or TBS/cholate (20 mM) (cholate associated assembly). ApoE422k 
(200-250 μg or 20 mg for large scale assembly) was added to the TBS/DMPC solution +/- cholate at a 
mass ratio of 4:1. The particle formation process was started with three repeated sets of transition 
temperature incubations, above (10 minutes at 30 °C, 20 minutes for large scale assembly) and below 
the transition temperature of DMPC (10 minutes at 20 °C, 20 minutes for large scale assembly) 
followed by incubation at 23.8 °C overnight (43 hours for large scale). Samples containing cholate 
were then dialyzed against 1000x volume of TBS buffer using 3 changes in 24 hrs. The NLPs were 
purified by size-exclusion chromatography using a Superdex 200 HR 10/300 column (GE Healthcare), 
in TBS at a flow rate of 0.5 mL/min or on a Superdex 200 26/60 at a flow rate of 2.5 mL/min for large 
scale preparations. The NLP fractions were concentrated to approximately 0.1 mg/mL using molecular 
weight sieve filters (Vivascience) with molecular weight cutoffs of 50 kDa. Protein concentration was 
determined using the ADV01 protein concentration kit (Cytoskeleton, Inc.).  
 
3.4. Atomic force microscopy (AFM) 
 
AFM images were acquired using a MFP-3D-CF AFM (Asylum Research, Santa Barbara, CA). 
Details of the imaging parameters have been described elsewhere [11,12].  
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3.5. Crystallization 
 
Sets of 384 sitting-drop experiments were designed using our CrysTool crystallization design 
engine (Segelke, JCG 2001). Experiments were setup in IntelliPlate sitting drop trays using 100 μL of 
reservoir cocktail and 400:400 μL reservoir:NLP stock solution drops. NLP stock solutions were at a 
protein concentration of 2 mg/mL as determined by a Bradford assay. Both the highly homogeneous 
and less homogeneous samples showed a high propensity to crystallize in nearly the same set of 
conditions, where the more homogeneous sample crystallizing with slightly higher propensity. The 
lower homogeneity sample gives microcrystals or better in ~26% of CrysTool generated conditions 
and the higher homogeneity sample gives microcrystals or better in ~35% of the conditions tested. In 
addition, the lower homogeneity sample gave microcrystals or better in ~26% of CrysTool generated 
conditions and the higher homogeneity sample gives microcrystals or better in ~35% of the conditions 
tested.  The large majority of conditions giving rise to NLP crystals are made up of mid molecular 
weight polyethylene glycol as the precipitating agent (2k-6k MW), a variety of buffer and range of pH 
(5.5-8.5). 
 
4. Conclusions  
 
In this study we found that NLPs assembled using the cholate-free method displayed a single peak 
and band by SEC and native gel, respectively, yet multiple sized particles were observed by AFM. In 
contrast, different sized NLPs, when the cholate-associated method was used, were effectively 
separated by SEC and native gel electrophoresis.  Surprisingly, this phenomenon appears to be limited 
to E422k containing NLPs since different sized NLPs assembled with other apolipoproteins, such as 
apoA1, using cholate-free assembly methods have been previously reported to display multiple peaks 
and bands by SEC and native gel, respectively [15,16,25-28]. However, in light of the results of this 
study, one must be mindful of the techniques used to assess sample homogeneity since under some 
assembly conditions (i.e. the use of apoE422k and cholate-free assembly) neither SEC nor native gel 
electrophoresis has the sufficient ability to assess homogeneity. Therefore coupling these low 
resolution analytical separation techniques to high resolution image tools such as atomic force 
microscopy may be important so that heterogeneity can be appreciated in lipoprotein samples which 
appear homogeneous and also so that more homogeneous NLP assemblies can be obtained by 
appropriately fractionating SEC elution peaks. Additional analytical tools may be important as well to 
further understand the mass distribution of irregularly sized particles such as the NLPs, notably flow-
field flow fractionation with multi-angle laser scattering detection (F4-MALS) [32,33]. We emphasize 
in this work that high resolution techniques can lead to a more rapid route to the generation of highly 
monodisperse self-assembled lipoproteins and crystal structures of them. 
When chromatography with extremely short elution times was used to deconvolute the elution 
pattern of the different sized NLPs under cholate-free assembly conditions, we found that the elution 
of the four NLP sizes was not consistent across the entire single NLP peak. In addition, through 
iterative SEC of this peak, we were able to achieve 90% homogeneity of the 14.5 nm sized NLP.  
Although this is one pathway to produce a homogeneous NLP subpopulation under cholate-free 
assembly conditions this is by no means the only method.  As was observed in the cholate-associated Int. J. Mol. Sci. 2009, 10                 
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assembly ~ 80% of the NLPs in the first NLP peak were 23.5 nm in size. Therefore, it is likely that 
fine elution chromatography may be used in conjunction with cholate-associated assembly for the 
purification of a highly homogeneous NLP subpopulation of 23.5 nm particles. Finally, when the 
homogeneous NLP sample, in addition to a heterogeneous sample, were subjected to de novo 
crystallization we were able to demonstrate that the homogeneous sample produced much higher 
quality crystals than the heterogeneous sample; thus, opening up the potential for structural 
determination by X-ray crystallography. 
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